Stephen Pastan Selected Research

Viremia

1/2021

CMV high-risk status and posttransplant outcomes in kidney transplant recipients treated with belatacept.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephen Pastan Research Topics

Disease

8	Chronic Kidney Failure (Chronic Renal Failure) 09/2019 - 03/2004
3	Infections 01/2021 - 08/2002
2	COVID-19 01/2022 - 12/2020
2	Renal Insufficiency (Renal Failure) 01/2021 - 05/2016
2	Lupus Nephritis 03/2016 - 03/2015
1	Viremia 01/2021
1	Kidney Diseases (Kidney Disease) 09/2019
1	Rapidly progressive glomerulonephritis with pulmonary hemorrhage 04/2005
1	Hereditary Nephritis (Alport Syndrome) 04/2005
1	Anti-Glomerular Basement Membrane Disease (Goodpasture's Syndrome) 04/2005
1	Fistula 08/2002

Drug/Important Bio-Agent (IBA)

2	Abatacept (Orencia)FDA Link 01/2021 - 12/2020
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2021
1	insulin receptor-related receptor (IRR)IBA 03/2016
1	anti-glomerular basement membrane autoantibodyIBA 04/2005
1	AntibodiesIBA 04/2005
1	Collagen Type IV (Type IV Collagen)IBA 04/2005
1	Urea (Carbamide)FDA LinkGeneric 03/2004

Therapy/Procedure

6	Kidney Transplantation 01/2021 - 01/2014
3	Transplantation 01/2022 - 05/2016
3	Renal Dialysis (Hemodialysis) 01/2008 - 08/2002
1	Catheters 08/2002